ETON•benzinga•
Eton Pharma Plans FDA Filing For ET-600 Oral Desmopressin Next Month, Eyes 2026 Launch
Summary
Eton Pharmaceuticals' ET-600 met bioequivalence standards in a study, with an FDA filing planned for April 2025 and a potential launch in early 2026.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 14, 2025 by benzinga